During the last years, in Romania and Bulgaria, an acceleration of existent disparities took place compared to the European Union countries as regards the occupational labor structures and an decreased evolution of the active population migration to other EU states. Starting from these considerations, the present paper shows an analysis of general and specific aspects of the labor market in the two neighbouring countries, starting from the general analysis, at national level, continuing with the regional analysis until the local analysis of the labor market, at cross border level. In Romania, in 2016, an employment rate of the population at work age (15-64 years old) was of 61.6%, to an active population of 8,979 thousand persons, of which 8,449 thousand employed persons and 530 thousand were unemployed. In Bulgaria, in 2016 the active population was of 3,264 thousand persons, respectively, 53.3%, of which 3,199.6 thousand employed persons and 64.4 thousand unemployed. The employment rate of the work was of 68.7%.. There are still signs that in the two countries the legislation complies to the realities and needs in practice.
Aim. Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are in a bidirectional relationship. This prospective study focused on associations between parameters common to the pathogenesis of insulin resistance, inflammation and hepatic steatosis in T2DM patients with metabolic imbalance.
Methods. We used clinical data, insulin resistance and inflammation indices, and hepatic steatosis markers from 120 patients.
Results. The patients (44% men, mean age 58) had a mean body mass index (BMI) of 32 kg/m2 and mean T2DM history of 6 years. With exceptions, significant correlations were found between metabolic, inflammatory and hepatic parameters.
Conclusions. In T2DM patients with poor glycemic control, hepatic steatosis correlates significantly with insulin resistance and inflammation. Increased prevalence and poor prognosis of these diseases together justify the need for NAFLD screening of diabetic patients.